Resumen
La cefalea por uso excesivo de medicamentos (CUEM) se define como la presencia de cefalea diaria o casi diaria (15 días o más de evolución), que se produce en pacientes con antecedente de cefalea primaria que usan excesivamente medicamentos. Está entidad está asociada a coomorbilidad psiquiátrica, por lo que las características clínicas se hacen más complejas con el paso del tiempo. El manejo fundamental se basa en la suspensión del medicamento sobre el que se centra el abuso (analgésicos, ergotamina, triptanes y opioides). Sin embargo, es necesario tomar en consideración que la suspensión de estos medicamentos puede asociarse a otros problemas como “cefalea de rebote”, síndrome de abstinencia o convulsiones epilépticas; incrementando las tasas de recaída en estos pacientes.
Citas
BOES CJ, CAPOBIANCO DJ. Chronic migraine and medication-overuse headache through the ages. Cephalalgia. 2005; 25: 378- 90.
PETERS GA, HORTON BT. Headache: with spe cial reference to excessive use of ergotamine preparations and withdrawal effects. Proceed Staff Meet Mayo Clin. 1951; 26:153-161.
HORTON BT, PETERS GA. Clinical manifestations of excessive use of ergotamine preparations and management of withdrawal effect: report of 52 cases. Headache. 1963; 3: 214-26.
Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988; 8 (S7): 1-96.
DIENER HC, LIMMROTH V. Medication overuse headache: a worldwide problem. Lancet Neurol. 2004; 3:475-83.
OLESEN J, BOUSSER M-G, DIENER H, ET AL. The international classification of headache disorders, 2nd edn. Cephalalgia. 2004; 24 (suppl 1): 1-160.
KATSARABA Z, DIENER HC, LIMMROTH V. Medication overuse headache: a focus on analgesics, ergot alkaloids and triptans. Drug safety 2001; 24: 921- 27.
CUPINI LM, CALABRESI P. Medication-overuse headache: pathophysiological insights. J Headache Pain 2005; 6:199-202.
GRAZZI L, ANDRASIK F. Medication-overuse headache: Description, treatment, and relapse prevent. Curr Pain. Headache Rep 10:71-77.
SAPER JR, HAMEL RL, LAKE AE III. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia 2005; 25:545-546.
LAMPL C, BUZATH A, YAZDI K ET AL. Ergot and triptan overuse in Austria - an evaluation of clinical data and cost. Cephalalgia 2002; 22:807-811.
PASCUAL J, COLAS R, CASTILLO J. Epidemiology of chronic daily headache. Curr Pain Headache Rep 2001;5:529-536.
SCHER AI, STEWART WF, RICCI JA, LIPTON RB. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003; 106:81-89.
SCHER AI, MIDGETTE LA, LIPTON RB. Risk Factors for Headache Chronification. Headache 2008; 48:16-25.
WANG SJ, FUH JL, LU SR, ET AL. Chronic daily headache in Chinese elderly: Prevalence, risk factors, and biannual follow-up. Neurology 2000; 54: 314-319.
CASTILLO J, MUNOZ P, GUITERA V, ET AL. Epidemiology of chronic daily headache in the general population. Headache 1999; 39:190-196.
RUEDA-SÁNCHEZ M,DÍAZ-MARTÍNEZ LA. Prevalence and associated factors for episodic and chronic daily headache in the Colombian population. Cephalalgia 2008; 28:216-225.
RAPOPORT A, STANG P, GUTTERMAN DL, ET AL. Analgesic rebound headache in clinical practice: data from a physician survey. Headache 1996; 36: 14-9.
ROBINSON RG. Pain relief for headaches. Can Fam Physician 1993; 39: 867-72.
MORILLO LE, ALARCON F, ARANAGA N, ET AL. Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries. Headache 2005;45:118-126.
DIENER HC, DAHLÖF CGH. Headache associated with chronic use of substances. Olesen J, Tfelt- Hansen P,WelchKMA, editors. The headaches. 2nd ed. Philadelphia: Lippincott,Williams & Wilkins, 1999: 871-8.
IMAI N, KITAMURA E, KONISHI T ET AL. Clinical features of probable medication-overuse headache: a retrospective study in Japan. Cephalalgia 2007; 27: 1020-1023.
ZEEBERG P, OLESEN J, JENSEN R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006; 66:1894-1898.
LIMMROTH V, KATSARAVA Z, FRITSCHE G, PRZYWARA S, DIENER HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002; 59:1011-14.
KATSARAVA Z, MUEBIG M, FRITSCHE G, DIENER HC, LIMMROTH V. Clinical features of withdrawal headache following overuse of triptans in comparison to other anti-headache drugs. Neurology 2001; 57:1694-1698.
DOWSON A, DODICK D, LIMMROTH V. Medication overuse headache in patients with primary headache disorders. Epidemiology, management and pathogenesis. Drugs 2005; 19: 483-497.
LANCE F, PARKES C, WILKINSON M. Does analgesic abuse cause headache de novo?. Headache 1988; 38: 61-62.
DOBSON CF, TOHYAMA Y, DIKSIC M, HAMEL E. Effects of acute or chronic administration of antimigraine drugs sumatriptan and zolmitriptan on serotonin synthesis in the rat brain. Cephalalgia 2004; 24: 2-11.
REUTER U, SALOMONE S, ICKENSTEIN G, WAEBER C. Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats. Cephalalgia 2004; 24: 398-407.
JI RR, WOOLF CJ. Neuronal plasticity and signal transduction in nociceptive neurons:implications for the initiation and maintenance of pathological pain. Neurobiol Dis 2001;8:1-10.
LAKE III AE, RAINS JC, PENZIEN DB, LIP- CHIK G. Headache and psychiatric comorbidity: historical context, clinical implications and research relevance. Headache 2005; 45:493-506.
RADAT F, CREAC'H C, SWENDSEN JD ET AL. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia 2005; 25:519-522.
ATASOY HT, UNAL AE, ATASOY N, ET AL. Low Income and Education Levels May Cause medication overuse and chronicity in Migraine Patients. Headache 2005; 45:25-31.
Baskin S, Lipchik G, Smitherman T. Mood and Anxiety Disorders in Chronic Headache. Headache 2006; 46 (Suppl3):76-87.
RADAT F, CREAC'H C, GUEGAN-MASSARDIER E ET AL. Behavioral dependence in patients with medication overuse headache: A cross-sectional study in consulting patients using the DSM-IV criteria. Headache 2008; 48:1026-1036.
FILIPPIS S, SALVATORI E, COLOPRISCO G ET AL. Headache and mood disorders. J Headache Pain 2005; 6:250-253.
LAKE III A. Medication Overuse Headache: Biobehavioral Issues and Solutions. Headache 2006; 46 (Suppl3):S88-S97.
SILBERSTEIN SD, LIPTON RB. Chronic daily headache. Curr Opin Neurol 2000; 13: 277-83.
DIENER H-C, TFELT-HANSEN P. Headache associated with chronic use of substances. In: Olesen J, Tfelt-Hansen P, Welch KMA, editors. The headaches. New York: Raven Press 1993; 721-7.
OLESEN J, BOUSSER MG, DIENER HC ET AL. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26:742-746.
SILBERSTEIN SD, OLESEN J, BOUSSER MG ET AL. The International Classification of Headache Disorders, 2nd Edition (ICHD-II) revision of criteria for 8.2 Medication-overuse headache. Cephalalgia 2005; 25: 460-465.
FREITAG F, LAKE AL III, LIPTON R ET AL. Inpatient treatment of headache: an evidence-based assessment. Headache 2004; 44:342-360.
GRAZZI L, ANDRASIK F, USAI S ET AL. In patient vs. day-hospital withdrawal treatment for chronic migraine with medication overuse and disability assessment: results at one-year follow-up. Neurol Sci (2008); 29:S161-S163.
SMITH T, STONEMAN J. Medication overuse headache from antimigraine therapy clinical features, pathogenesis and management. Drugs 2004; 64(22): 2503-2514.
How clinicians can detect, prevent and treat medication overuse headache. Cephalalgia 2008; 28:1209- 1217.
PASCUAL J, MATEOS V, GRACIA M. Medication overuse headache in Spain. Cephalalgia 2008; 28:1234- 1236.
GRAZZI L, ANDRASIK F, USAI S ET AL. Treatment of chronic migraine with medication overuse: is drug withdrawal crucial?. Neurol Sci 2009; 30 (S 1):S85-S88.
JENSEN R, BENDTSEN L. Medication overuse headache in Scandinavia. Cephalalgia 2008; 28:1237- 1239.
RASKIN NH. Repetitive intravenous dihydro ergotamine as therapy for intractable migraine. Neurology 1986; 36:995-997.
KATSARAVA Z, DIENER HC. Medication over use headache in Germany. Cephalalgia 2008; 28:1221- 1222.
WANG SJ, FUH JL. Medication overuse headache in Taiwan. Cephalalgia 2008; 28:1240-1242.
KRYMCHANTOWSKI AV, BARBOSA JS. Prednisone as initial treatment of analgesic-induced daily headache. Cephalalgia 2000; 20:107-113.
ZEEBERG P, OLESEN J, JENSEN R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia 2006; 26:1192-8.
KATSARAVA Z, LIMMROTH V, FINKE M, ET AL. Rate and predictors for relapse in medication overuse headache: a one year prospective study. Neurology 2003; 60: 1682-3.
FRITSCHE G, EBERLA, KATSARAVA Z, ET AL. Drug-induced headache: long-term follow-up of withdrawal therapy and persistence of drug misuse. Eur Neurol 2001; 45: 229-35.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.